Category - Executive Moves

Executive Moves

Soricimed names Dr. Marc Rubin and Vaughn Embro-Pantalony to board

Closely-held Soricimed Biopharma has appointed accomplished biotech and pharma Industry veterans, Marc Robin, MD and Vaughn Embry-Pantalony to its board, effective immediately. In a statement, Tom Reeves, chairman, said...

March 20, 2018

Executive Moves

NY investment community veteran, Miranda Toledano, joins HCW in Israel

Miranda Toledano has joined H.C. Wainwright's healthcare investment banking team where she will focus on building out the firm's footprint across Europe and Israel.

February 15, 2018

Executive Moves

Eiger BioPharma names Eldon Mayer to board

Eiger BioPharmaceuticals (NASDAQ:EIGR) appointed Eldon Mayer as a director, while Chuck Bramlage has left the board to focus on a newly accepted position as CEO at another start-up company.

January 8, 2018

Executive Moves

Ortho RTi names Sharon Ludlow as a director

Ortho Regenerative Technologies (CSE:ORTH) appointed Sharon Ludlow to the board, succeeding Laurence Rulleau, who has resigned.

January 8, 2018

Executive Moves

Eiger BioPharma names Dr. David Apelian as COO, EMO

Eiger BioPharmaceuticals (NASDAQ:EIGR) appointed Dr. David Apelian as chief operating officer and executive medical officer.

January 3, 2018

Executive Moves

Analysts start Quanterix at OP, buy; PTs $27, $26

Analysts at Leerink and BTIG launched coverage of Quanterix (NASDAQ:QTRX) with “outperform” and “buy” ratings, respectively, and price targets of $27 and $26, respectively. The stock closed at $21.47 on Dec. 29.

January 2, 2018

Executive Moves